Co-Authors
This is a "connection" page, showing publications co-authored by Masahiro Ishikane and Norio Ohmagari.
Connection Strength
6.848
-
A Case of COVID-19 Patient with False-Negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese Traveller Returning from Wuhan, Hubei Province, China, January 2020. Jpn J Infect Dis. 2020 Nov 24; 73(6):462-464.
Score: 0.884
-
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503.
Score: 0.240
-
Clinical and radiological findings of silent hypoxia among COVID-19 patients. J Infect Chemother. 2021 Oct; 27(10):1536-1538.
Score: 0.239
-
A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea. Jpn J Infect Dis. 2022 Jan 24; 75(1):36-40.
Score: 0.237
-
Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256.
Score: 0.236
-
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067.
Score: 0.235
-
External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050.
Score: 0.235
-
Acute portal vein thrombosis with COVID-19 and cirrhosis. IDCases. 2021; 24:e01094.
Score: 0.234
-
Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486.
Score: 0.233
-
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133.
Score: 0.228
-
Periungual desquamation in a Japanese Adult recovering from severe COVID-19. Int J Infect Dis. 2021 Jan; 102:37-39.
Score: 0.227
-
Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098.
Score: 0.227
-
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122.
Score: 0.225
-
Case of adult large vessel vasculitis after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Aug 11.
Score: 0.224
-
COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
Score: 0.222
-
A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan. Glob Health Med. 2020 Jun 30; 2(3):190-192.
Score: 0.222
-
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
Score: 0.222
-
Continuous Renal Replacement Therapy for a Patient with Severe COVID-19. Blood Purif. 2021; 50(1):129-131.
Score: 0.222
-
Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020 08; 48(8):969-971.
Score: 0.221
-
Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853.
Score: 0.220
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040.
Score: 0.220
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040.
Score: 0.220
-
What is the impact of the change in DDD of amoxicillin and amoxicillin combined with ß-lactamase inhibitors on nationwide surveillance of antimicrobial use? J Antimicrob Chemother. 2019 10 01; 74(10):3119-3121.
Score: 0.211
-
Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan. J Infect Chemother. 2019 May; 25(5):396-399.
Score: 0.199
-
Dengue Virus Exported from Côte d'Ivoire to Japan, June 2017. Emerg Infect Dis. 2017 10; 23(10).
Score: 0.184
-
Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan. PLoS One. 2017; 12(7):e0181548.
Score: 0.182
-
Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19. Glob Health Med. 2021 Apr 30; 3(2):115-118.
Score: 0.059
-
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
Score: 0.057
-
Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus disease 2019. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020969492.
Score: 0.057
-
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
Score: 0.056
-
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
Score: 0.056
-
Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan. Emerg Infect Dis. 2020 Nov; 26(11):2758-2761.
Score: 0.056
-
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111.
Score: 0.055